Share Issue News

SASKATOON, Saskatchewan--(BUSINESS WIRE)--ZYUS Life Sciences Corporation (the “Company” and/or “ZYUS”) (TSX-V: ZYUS), a clinical stage life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates, today announced that the European Patent Office has granted and the opposition period has expired respecting patent No. EP 3962473 entitled “Formulation For Pain Management”. This patent relates to ZYUS’ cannabinoid-based lead drug ca...

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on April 30, 2025. Three individuals were hired by Adicet in April 2025. In the aggregate, Adicet granted new hires non-qualified stock options to purchase 206,800 shares of Adicet’s common stock with an exercise price of $0.66 per...

PARIS--(BUSINESS WIRE)--Regulatory News: In accordance with its policy in favor of employee shareholding, TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) (the “Corporation”) is implementing its annual capital increase reserved for employees and former employees of the TotalEnergies company (the “Company”). Through this operation, TotalEnergies SE intends to continue involving its employees in the Company’s growth. Employee shareholders, within the meaning of Article L. 225-102 of the French C...

DENVER--(BUSINESS WIRE)--TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (the “Company”), an oncology focused medical technology business seeking to transform outcomes for patients with solid tumors by integrating its innovative delivery technology with standard-of-care therapies, and with its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 agonist, for a range of different therapeutic and technology applications, today announces preliminary financial results for Q1 2...

LA DÉFENSE, France--(BUSINESS WIRE)--Regulatory News: In accordance with applicable regulations, Arkema (Paris:AKE) announces having carried out the following share buyback transactions in accordance with Article 5 §2 of Regulation (EU) No 596/2014 from 22 April to 22 April 2025 Name of the issuer Issuer identifier code Day of the transaction Financial instrument identifier code Total daily volume (number of shares) Weighted average price of daily acquisition Market identifier code ARKEMA 96950...

BILLERICA, Mass. & MARLBOROUGH, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection, and Akoya Biosciences (NASDAQ: AKYA), The Spatial Biology Company®, today announced an amendment to the terms of their previously announced merger agreement. Under the amended terms, Quanterix will issue approximately 7.76 million shares of its common stock and pay $20 million in cash to Akoya shareholders. Each Akoya s...

SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today announced the appointment of Timothy Watkins, M.D., M.Sc., to the Company’s executive team as its Chief Medical Officer and Head of Development. Effective immediately, Dr. Watkins will lead all clinical development and medical...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS 529900JEHFM47DYY3S57 22/03/2025 FR0014000MR3 88,000 49.0621 XPAR EUROFINS 529900JEHFM47DYY3S57 22/03/2025 FR0014000MR3 54,000 49.0614 CEUX EUROFINS 529900JEHFM47DYY3S57 22/03/2025 FR0014000MR3 4,000...

WASHINGTON--(BUSINESS WIRE)--Easterly Government Properties, Inc. (NYSE: DEA) (the “Company” or “Easterly”), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to U.S. Government agencies, today announced that it completed its previously announced reverse stock split of the Company’s common stock (the “Common Stock”) at a ratio of 1-for-2.5 (the “Reverse Stock Split”). At market open on April 2...

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Energy Vault Holdings, Inc. (“Energy Vault”) (NYSE: NRGV), a global energy storage company today announced that, effective on March 5, 2025, the Compensation Committee of Energy Vault’s Board of Directors granted to 12 new, non-executive employees, restricted stock unit awards covering 637,600 shares of its common stock under the Energy Vault Holdings, Inc. 2022 Employment Inducement Award Plan (as amended and/or restated, the “Inducement Award Plan”)....